Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 132

1.

Progression of mouse mammary tumors: MCP-1-TNFalpha cross-regulatory pathway and clonal expression of promalignancy and antimalignancy factors.

Neumark E, Sagi-Assif O, Shalmon B, Ben-Baruch A, Witz IP.

Int J Cancer. 2003 Oct 10;106(6):879-86.

2.

Possible co-regulation of genes associated with enhanced progression of mammary adenocarcinomas.

Neumark E, Cohn MA, Lukanidin E, Witz IP, Ben-Baruch A.

Immunol Lett. 2002 Jun 3;82(1-2):111-21.

PMID:
12008042
3.

MCP-1 expression as a potential contributor to the high malignancy phenotype of murine mammary adenocarcinoma cells.

Neumark E, Anavi R, Witz IP, Ben-Baruch A.

Immunol Lett. 1999 May 3;68(1):141-6.

PMID:
10397169
4.

Regulation of the inflammatory profile of stromal cells in human breast cancer: prominent roles for TNF-α and the NF-κB pathway.

Katanov C, Lerrer S, Liubomirski Y, Leider-Trejo L, Meshel T, Bar J, Feniger-Barish R, Kamer I, Soria-Artzi G, Kahani H, Banerjee D, Ben-Baruch A.

Stem Cell Res Ther. 2015 May 1;6:87. doi: 10.1186/s13287-015-0080-7.

5.

Interleukin-1beta and tumor necrosis factor-alpha induce chemokine and matrix metalloproteinase gene expression in human colonic subepithelial myofibroblasts.

Okuno T, Andoh A, Bamba S, Araki Y, Fujiyama Y, Fujiyama M, Bamba T.

Scand J Gastroenterol. 2002 Mar;37(3):317-24.

PMID:
11916194
6.

Effects of the MCP-1 synthesis inhibitor bindarit on tumorigenesis and inflammatory markers in the C3(1)/SV40Tag mouse model of breast cancer.

Steiner JL, Davis JM, McClellan JL, Guglielmotti A, Murphy EA.

Cytokine. 2014 Mar;66(1):60-8. doi: 10.1016/j.cyto.2013.12.011. Epub 2014 Jan 20.

7.

Inflammatory mediators in breast cancer: coordinated expression of TNFα & IL-1β with CCL2 & CCL5 and effects on epithelial-to-mesenchymal transition.

Soria G, Ofri-Shahak M, Haas I, Yaal-Hahoshen N, Leider-Trejo L, Leibovich-Rivkin T, Weitzenfeld P, Meshel T, Shabtai E, Gutman M, Ben-Baruch A.

BMC Cancer. 2011 Apr 12;11:130. doi: 10.1186/1471-2407-11-130.

8.

GM-CSF up-regulates the expression of CCL2 by T lymphocytes in mammary tumor-bearing mice.

Owen JL, Torroella-Kouri M, Handel-Fernandez ME, Iragavarapu-Charyulu V.

Int J Mol Med. 2007 Jul;20(1):129-36.

PMID:
17549399
9.

Ethanol promotes mammary tumor growth and angiogenesis: the involvement of chemoattractant factor MCP-1.

Wang S, Xu M, Li F, Wang X, Bower KA, Frank JA, Lu Y, Chen G, Zhang Z, Ke Z, Shi X, Luo J.

Breast Cancer Res Treat. 2012 Jun;133(3):1037-48. doi: 10.1007/s10549-011-1902-7. Epub 2011 Dec 9.

10.

Cytokine regulation of CC and CXC chemokine expression by human astrocytes.

Oh JW, Schwiebert LM, Benveniste EN.

J Neurovirol. 1999 Feb;5(1):82-94.

PMID:
10190694
12.

Raf kinase inhibitor protein suppresses nuclear factor-κB-dependent cancer cell invasion through negative regulation of matrix metalloproteinase expression.

Beshir AB, Ren G, Magpusao AN, Barone LM, Yeung KC, Fenteany G.

Cancer Lett. 2010 Dec 28;299(2):137-49. doi: 10.1016/j.canlet.2010.08.012. Epub 2010 Sep 19.

13.

Expression of the chemokines IP-10 and Mig in IL-10 transduced tumors.

Sun H, Kundu N, Dorsey R, Jackson MJ, Fulton AM.

J Immunother. 2001 Mar-Apr;24(2):138-43.

PMID:
11265771
14.

Stromal MCP-1 in mammary tumors induces tumor-associated macrophage infiltration and contributes to tumor progression.

Fujimoto H, Sangai T, Ishii G, Ikehara A, Nagashima T, Miyazaki M, Ochiai A.

Int J Cancer. 2009 Sep 15;125(6):1276-84. doi: 10.1002/ijc.24378.

15.

The expression of the chemokine receptor CXCR3 and its ligand, CXCL10, in human breast adenocarcinoma cell lines.

Goldberg-Bittman L, Neumark E, Sagi-Assif O, Azenshtein E, Meshel T, Witz IP, Ben-Baruch A.

Immunol Lett. 2004 Mar 29;92(1-2):171-8.

PMID:
15081542
16.

Keratinocytes from patients with atopic dermatitis and psoriasis show a distinct chemokine production profile in response to T cell-derived cytokines.

Giustizieri ML, Mascia F, Frezzolini A, De Pità O, Chinni LM, Giannetti A, Girolomoni G, Pastore S.

J Allergy Clin Immunol. 2001 May;107(5):871-7.

PMID:
11344355
17.

STAT1-deficient mice spontaneously develop estrogen receptor α-positive luminal mammary carcinomas.

Chan SR, Vermi W, Luo J, Lucini L, Rickert C, Fowler AM, Lonardi S, Arthur C, Young LJ, Levy DE, Welch MJ, Cardiff RD, Schreiber RD.

Breast Cancer Res. 2012 Jan 20;14(1):R16.

18.

Cross-talk among myeloid-derived suppressor cells, macrophages, and tumor cells impacts the inflammatory milieu of solid tumors.

Beury DW, Parker KH, Nyandjo M, Sinha P, Carter KA, Ostrand-Rosenberg S.

J Leukoc Biol. 2014 Dec;96(6):1109-18. doi: 10.1189/jlb.3A0414-210R. Epub 2014 Aug 28.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk